Assenagon Asset Management
KIN

Assenagon Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Assenagon Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$1.16M Buy
2019
Q2 		– Sell
2019
Q1 		$511K Sell
2018
Q4 		$1.86M Buy